Cancer: Drugs

Department of Health written question – answered on 17th November 2015.

Alert me about debates like this

Photo of Nicholas Dakin Nicholas Dakin Shadow Minister (Education)

To ask the Secretary of State for Health, pursuant to the Answer of 16 September 2015 to Question 10091, what the implications for his policies are of the decision by NHS England to remove (a) the pancreatic cancer drug Abraxane and (b) 22 other drugs and indications from the Cancer Drugs Fund List.

Photo of George Freeman George Freeman The Parliamentary Under-Secretary of State for Business, Innovation and Skills, The Parliamentary Under-Secretary of State for Health

We remain committed to continuing to invest in the Cancer Drugs Fund (CDF).

NHS England is responsible for the operational management of the Fund. Following appeals and further discussions with pharmaceutical companies, 18 drug and indication combinations, including Abraxane for pancreatic cancer, were removed from the national CDF list on 4 November 2015.

Does this answer the above question?

Yes0 people think so

No1 person thinks not

Would you like to ask a question like this yourself? Use our Freedom of Information site.